$GILD: Nice setup for a month...Gilead offers a very nice setup here, upside as per the chart. You can expect it to do well during January if it holds over $85.43 for the most part, might consolidate again after February the 1st. Best of luck if taking this one. Cheers, Ivan Labrie.Longby IvanLabrieUpdated 2
GILD SELL+++++ GILD has been stubborn AF on correcting, it will eventually and likely after my puts expire Jan 20 lol. Shortby ShortSeller762
🟩 $GILD - taking a pilot here- Stock is getting in an early stage 2 - Buying off a low cheat - Gross Margins increase - Industry group is strongLongby TintinTrading2
GILD triple top failedGILD has been on a monster run, up one day, up the next and failed to pierce through the triple top. Bio pharma stocks are always difficult both short and long, every time I trade one it's always the last time. LOL $71 gap to fillShortby ShortSeller76Updated 223
Bear swing on GILDREALLY nice bull inside candle at a nice high. After a run up.. This would be VERY interesting short. I have zero issue losing 1R on this trade. However, I did mention in a Forbes article that big pharma is PROB going to be the best performing asset / sector From Oct 2022 to April 2023 (mid term election cycle) Shortby Reallifetrading444
GILD SELL+ Overbought GILD should correct back to $70-73 before any further leg up, further breakout to the upside can happen. Shortby ShortSeller76Updated 334
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 50%. Longby EPSMomentum0
After Earnings- 66-67 area. SHORTI believe a bad earnings call will send GIld to 66 area with ease. Shortby Futuresfunn3
Gilead SciencesBreaking out. GILD has broken a long term downtrend and is now targeting $74.50 Longby Trad3r_161
Buy $GILD - NRPicks 25 FebGilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes drugs in areas of unmet medical need such as human immunodeficiency virus (HIV) in the United States, Europe and internationally. Revenue TTM 27.3B Net Income TTM 6.2B EBITDA TTM 12.5B Debt/EBITDA TTM 2.5x EBITDA Margin 45.9% Net Margin 22.8%Longby NewroadTraderUpdated 2
QuickTrade : GILDNice box testing the 250h. The 50h and the 21h want to move on the right order after this pullback. The previous high can be a target, while a breakdown has more targets.by TizyCharts0
GILD Swing IdeaSwing idea for GILD if it can stay above this zone. Looking at 9/16 calls. Focusing on $65 and $67.5 strikes. They have a combined OI of 26,125Longby dting71
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 33.33%. Longby EPSMomentum0
Shorting Gilead. GILDIndeed. B Wave in a zigzag form appears to be completed. We are going down to one extent to another. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.Shortby Rykin_CapitalUpdated 2
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%. Longby EPSMomentum0
14/4/2022 NASDAQ (GILD)Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price. Entry Price: $61.83 Target Price: $62.45 Stop Loss: $61.21Longby Airecap_HyperUpdated 0
28/3/2022 NASDAQ (GILD)Short (Entry Price) below the black line and exit (Stop Loss) above the red line. Can take profit at the suggested Target Price. Entry Price: $58.87 Target Price: $58.47 Stop Loss: $59.54Shortby Airecap_HyperUpdated 0
$GILD with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $GILD after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 62.5%.Longby EPSMomentum0
Bias more on upside. 05th March 2022 Gilead 56 final support. worth to take risk price between 56-60 TP64 & 68 Nimble safeLongby probabilityta112
Gilead Sciences: Boom Times Ahead? - Potential Run to +$110 areaNASDAQ:GILD Early Long Idea on Gilead Sciences Gilead has navigated 2/3rds of a huge arc that has been forming since 2015, and the arc is beginning to slope vertical. Price navigated the yellow pitchfork on the way down, and now is beginning to be directed by the purple upsloping fork. Weekly Stoch RSI is approaching oversold levels. I will wait for a momentum signal or another strong arc retest before going long with a long dated call / LEAP. Just an idea right now, with a lot of upside. Longby Cousin_Fat_FatUpdated 1
ABC BullishTarget is D GILD has broken the neckline of an inverse head and shoulders pattern and possibly forming a cup. No recommendationby lauralea222
Gild is at it's final face of accumulation?I believe Gilead has made it's final low on Oct 29th. These Wyckoff accumulation patterns are very powerful reversal patterns. I will be more convinced if price breaks above the red line resistance. If that that happens, , I will start adding GILD on my portfolio. Good luck everyoneby FreedomBuilder2